A Clinical Practice Guideline Summary for Pharmacological Management of Adults with Major Depressive Disorder in Malaysia

被引:0
|
作者
Abousheishaa, Aya Ahmed [1 ]
Sue-Yin, Low [2 ]
Khin, Kok Chee [3 ]
Sulaiman, Ahmad Hatim [1 ]
Huri, Hasniza Zaman [4 ]
Guan, Ng Chong [1 ]
机构
[1] Univ Malaya, Dept Psychol Med, Fac Med, Kuala Lumpur, Malaysia
[2] HELP Univ, Fac Behav Sci, Dept Psychol, Kuala Lumpur, Malaysia
[3] Univ Malaya, Dept Pharm, Med Ctr, Kuala Lumpur, Malaysia
[4] Univ Malaya, Fac Pharm, Kuala Lumpur, Malaysia
关键词
Major depressive disorder; clinical practice guidelines; evidence-based practice; RECOMMENDATIONS; ADAPTATION; ADHERENCE; MOOD;
D O I
10.9734/JPRI/2021/v33i45B32821
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Clinical Practice Guidelines (CPGs) are systematically developed statements to assist practitioners and patients with appropriate health care for specific clinical circumstances. However, evidence suggests that the uptake of these recommendations in routine care is still limited, particularly in resource-constrained countries. Objectives: This article aimed to (1) identify current CPGs for the pharmacological management of MDD that address and are compatible with the needs of Malaysian psychiatrists (2) collate and summarise these CPG recommendations to produce a more culturally sensitive and end-user friendly guideline summary. Materials and Methods: A multidisciplinary steering group followed an adapted development approach that included; (1) searching for guidelines on the pharmacological management of adults with depression, (2) screening them for relevant recommendations, (3) critical appraising these guidelines, and (4) extracting the required information. A panel of experts then reviewed the developed guideline summary. Results: Six potentially relevant guidelines for the pharmacological management of depression in adults were identified. The developed summary included a decision algorithm to guide the selection of antidepressant therapy based on clinical factors, potential drug-drug interaction, tolerability, and cost of the medications. The review panel considered the summary recommendations easy to use and had the potential for uptake by busy psychiatrists. Conclusion: A CPG summary for the pharmacological management of depression was developed that focuses on evidence-based, contextually relevant recommendations that are feasible for implementation within the local healthcare settings in Malaysia. Practical Implications: The developed guideline summary has the potential to enhance the implementation of evidence-based practice in the management of Major Depressive Disorder within the Malaysian context.
引用
收藏
页码:405 / 411
页数:7
相关论文
共 50 条
  • [31] Pharmacological treatment of major depressive disorder in adolescents
    Farley, Rachel L.
    THESCIENTIFICWORLDJOURNAL, 2005, 5 : 420 - 426
  • [32] Appraisal of Clinical Practice Guideline: CRISM National Guideline for the Clinical Management of Opioid Use Disorder
    Lu, Ze
    JOURNAL OF PHYSIOTHERAPY, 2020, 66 (04) : 272 - 272
  • [33] Fatigue in Patients with Major Depressive Disorder: Prevalence, Burden and Pharmacological Approaches to Management
    Ghanean, Helia
    Ceniti, Amanda K.
    Kennedy, Sidney H.
    CNS DRUGS, 2018, 32 (01) : 65 - 74
  • [34] Fatigue in Patients with Major Depressive Disorder: Prevalence, Burden and Pharmacological Approaches to Management
    Helia Ghanean
    Amanda K. Ceniti
    Sidney H. Kennedy
    CNS Drugs, 2018, 32 : 65 - 74
  • [35] Major Depressive Disorder in Older Patients as an Inflammatory Disorder: Implications for the Pharmacological Management of Geriatric Depression
    Malcolm P. Forbes
    Adrienne O’Neil
    Melissa Lane
    Bruno Agustini
    Nick Myles
    Michael Berk
    Drugs & Aging, 2021, 38 : 451 - 467
  • [36] Major Depressive Disorder in Older Patients as an Inflammatory Disorder: Implications for the Pharmacological Management of Geriatric Depression
    Forbes, Malcolm P.
    O'Neil, Adrienne
    Lane, Melissa
    Agustini, Bruno
    Myles, Nick
    Berk, Michael
    DRUGS & AGING, 2021, 38 (06) : 451 - 467
  • [37] The Saudi clinical practice guideline for the management of overweight and obesity in adults
    Alfadda, Assim A.
    Al-Dhwayan, Madhawi M.
    Alharbi, Abdulhameed A.
    Al Khudhair, Basema K.
    Al Nozha, Omar M.
    Al-Qahtani, Nawal M.
    Alzahrani, Saad H.
    Bardisi, Wedad M.
    Sallam, Reem M.
    Riva, John J.
    Brozek, Jan L.
    Schunemann, Holger J.
    Moore, Ainsley
    SAUDI MEDICAL JOURNAL, 2016, 37 (10) : 1151 - 1162
  • [38] Escitalopram A Review of its Use in the Management of Major Depressive Disorder in Adults
    Garnock-Jones, Karly P.
    McCormack, Paul L.
    CNS DRUGS, 2010, 24 (09) : 769 - 796
  • [39] EscitalopramA Review of its Use in the Management of Major Depressive Disorder in Adults
    Karly P. Garnock-Jones
    Paul L. McCormack
    CNS Drugs, 2010, 24 : 769 - 796
  • [40] Antipsychotic augmentation for major depressive disorder: A review of clinical practice guidelines
    Simons, Peter
    Cosgrove, Lisa
    Shaughnessy, Allen F.
    Bursztajn, Harold
    INTERNATIONAL JOURNAL OF LAW AND PSYCHIATRY, 2017, 55 : 64 - 71